FDA chính thức chấp thuận thuốc trị đại dịch vũ hán đầu tiên: REMDESIVIR...
do viện bào chế Gilead Sciences Inc. tại California sản xuất...
Xin chuyển tin đến Quý Vị, Quý NT và CH....
FDA chính thức chấp thuận thuốc trị đại dịch vũ hán đầu tiên: REMDESIVIR...
do viện bào chế Gilead Sciences Inc. tại California sản xuất...
Xin mời Quý Vị theo dõi bản tin ở dưới để tường..
BMH ///
Washington, D.C
FDA approves first COVID-19 drug: antiviral remdesivir
MARILYNN MARCHIONE
Oct 22nd 2020 6:04PM
U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
It had been authorized for use on an emergency basis since spring, and now becomes the first drug to win full Food and Drug Administration approval for treating COVID-19. President Donald Trump received it when he was sickened earlier this month.
Gilead charges $2,340 for a typical treatment course for people covered by government health programs in the United States and other developed countries, and $3,120 for patients with private insurance. The amount that patients pay out of pocket depends on insurance, income and other factors.
Xin mời xem toàn văn bản tin ở link dưới: